Diego A. Gianolio - Concepedia

Author

Diego A. Gianolio

Also Known As

D. A. Gianolio, D. Gianolio, Diego A Gianolio, Diego A. Gianolio, Diego Alberto Gianolio, Diego Gianolio, Genzyme Analytical Services, Gianolio, D.A.

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Sanofi (United States)Boston College Centre Hospitalier Universitaire de Toulouse Institut Gustave Roussy Princess Margaret Cancer Centre

About

Diego A. Gianolio is an author at Sanofi (United States) specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	374
2	Natural Sciences	4	4	294
3	Engineering	2	2	28
4	Health Sciences	2	2	40
5	Anesthesia	1	1	21

Diego A. Gianolio

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia Pau Montesinos, Christian Récher, Susana Vives, New England Journal of Medicine	2022	448
Site-Specific Antibody–Drug Conjugation through Glycoengineering Qun Zhou, James E. Stefano, Charlene Manning, Bioconjugate Chemistry Site-specific Antibody–drug ConjugationMedicinal ChemistryNative GlycansBioorganic ChemistryBiochemistry	2014	213
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia Courtney D. DiNardo, Anthony S. Stein, Eytan M. Stein, Journal of Clinical Oncology	2020	170
Oxidative Repair of a Thymine Dimer in DNA from a Distance by a Covalently Linked Organic Intercalator David A. Vicic, Duncan T. Odom, Megan E. Núñez, Journal of the American Chemical Society	2000	60
Long-Range Guanine Oxidation in DNA Restriction Fragments by a Triplex-Directed Naphthalene Diimide Intercalator Megan E. Núñez, Katherine T. Noyes, Diego A. Gianolio, Biochemistry	2000	55
Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein George E. Durán, Volker Derdau, Dietmar Weitz, Cancer Chemotherapy and Pharmacology Chemical BiologyBiochemistryNatural SciencesMolecular BiologyCell Lines	2018	53
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement Ada Gjyrezi, Fang Xie, Olga Voznesensky, Journal of Clinical Investigation UrologyOncologyDecreased Drug-target EngagementGenitourinary CancerMedicine	2020	52
Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies Cécile Rouleau, Diego A. Gianolio, Robert Smale, Molecular Cancer Therapeutics Tumor BiologyMalignant DiseaseMedicineAntibody-drug ConjugateAnti-endosialin Antibody–drug Conjugate	2015	36
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates Diego A. Gianolio, Cécile Rouleau, William E. Bauta, Cancer Chemotherapy and Pharmacology Tumor BiologyNovel Antibody–drug ConjugatesDrug TargetingOncologyDolastatin 15	2012	33
Tethered naphthalene diimide-based intercalators for DNA triplex stabilization Diego A. Gianolio Nucleic Acids Research	2000	33

Page 1